Precipio Presents Poster on HemeScreen® Study at Association of Molecular Pathology (AMP) 2022 Annual Conference
November 07, 2022 10:30 ET
|
Precipio, Inc.
NEW HAVEN, Conn., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) presented at the annual 2022 AMP conference a poster presentation of the...
Precipio Announces Third Quarter Shareholder Update Call
November 02, 2022 17:00 ET
|
Precipio, Inc.
NEW HAVEN, Conn., Nov. 02, 2022 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Q3-2022 shareholder update call on Monday, November 14th...
Precipio Signs Agreement with Another Major US Healthcare Distributor for HemeScreen™
September 15, 2022 11:00 ET
|
Precipio, Inc.
NEW HAVEN, Conn., Sept. 15, 2022 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), has signed a distribution agreement for HemeScreen with a major distribution...
Sharon Robins Joins Precipio’s Products Division as Senior Director of Laboratory & Hospital Sales
August 24, 2022 11:00 ET
|
Precipio, Inc.
NEW HAVEN, Conn., Aug. 24, 2022 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), welcomes Sharon Robins as the Company’s Senior Director of Laboratory &...
Precipio Launches New 1-Step Technology for all HemeScreen Assays
August 16, 2022 11:00 ET
|
Precipio, Inc.
NEW HAVEN, Conn., Aug. 16, 2022 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), announces the launch of its second generation of HemeScreen panels. Precipio’s...
Toni-Ann Mills Joins Precipio’s Products Division to Lead Channel Partner Training, Learning & Development
August 10, 2022 10:00 ET
|
Precipio, Inc.
NEW HAVEN, Conn., Aug. 10, 2022 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), welcomes Toni-Ann Mills as the Company’s Senior Director for Learning &...
Precipio Announces Second Quarter Shareholder Update Call
August 08, 2022 10:00 ET
|
Precipio, Inc.
NEW HAVEN, Conn., Aug. 08, 2022 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Q2-2022 shareholder update call on Monday, August 15th at...
Precipio to distribute HemeScreen® through Fisher Healthcare channel
July 20, 2022 10:30 ET
|
Precipio, Inc.
NEW HAVEN, Conn., July 20, 2022 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), today announced that it has entered into an agreement with Fisher Healthcare,...
Precipio requests that all Stockholders that have not yet voted, proceed to cast their vote
June 14, 2022 14:00 ET
|
Precipio, Inc.
NEW HAVEN, Conn., June 14, 2022 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ:PRPO), announced today that the Company’s 2022 Annual Meeting of Stockholders was adjourned...
Keith Meadors Joins Precipio to Lead its Products Division
June 13, 2022 11:00 ET
|
Precipio, Inc.
NEW HAVEN, Conn., June 13, 2022 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company, Precipio, Inc. (NASDAQ: PRPO), today announced that Keith Meadors has joined Precipio as its Senior Vice...